These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16838558)

  • 21. The biphasic transmittance waveform: an early marker of sepsis in patients with neutropenia.
    Hussain N; Hodson D; Marcus R; Baglin T; Luddington R
    Thromb Haemost; 2008 Jul; 100(1):146-8. PubMed ID: 18612549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.
    Lamoth F; Buclin T; Csajka C; Pascual A; Calandra T; Marchetti O
    Antimicrob Agents Chemother; 2009 Feb; 53(2):785-7. PubMed ID: 19047655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient oral antibiotics for febrile neutropenic cancer patients.
    Ouvrier MJ; Thery JC; Blot E
    J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pseudomonas aeruginosa septicemia in onco-hematology. Report of 22 cases].
    Laatiri MA; Boukadida J; Chehata S; Hadj F; el Omri H; Ennabli S
    Tunis Med; 1998; 76(8-9):229-33. PubMed ID: 9810857
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of a Protective Environment implementation for cancer patients with chemotherapy-induced neutropenia on fever and mortality incidence.
    Stoll P; Silla LM; Cola CM; Splitt BI; Moreira LB
    Am J Infect Control; 2013 Apr; 41(4):357-9. PubMed ID: 23102987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withholding antibiotics from patients with febrile neutropenia.
    Lyman GH
    J Clin Oncol; 2006 Mar; 24(7):1221-2; author reply 1222-3. PubMed ID: 16505444
    [No Abstract]   [Full Text] [Related]  

  • 27. Relevant aspects in the Infectious Diseases Society of America (IDSA) guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Zinner SH
    Int J Hematol; 1998 Oct; 68 Suppl 1():S31-4. PubMed ID: 9838742
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial.
    Svahn BM; Bjurman B; Myrbäck KE; Aschan J; Ringdén O
    Presse Med; 2004 Apr; 33(7):474-8. PubMed ID: 15105770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Febrile neutropenia--seven frequently asked questions and answers.
    Krcmery V; Beno P
    Hematology; 2005; 10 Suppl 1():231-3. PubMed ID: 16188680
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Cornely OA; Ullmann AJ; Karthaus M
    J Antimicrob Chemother; 2006 Jan; 57(1):151-2; author reply 152-4. PubMed ID: 16314347
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing hematologic toxicities in the oncology patient.
    Montoya L
    J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections in neutropenic patients. II: Management.
    Engervall P; Björkholm M
    Med Oncol; 1996 Mar; 13(1):63-9. PubMed ID: 8869939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The immunosuppressed patient with opportunistic infection. This is now the responsibility of the general practitioner].
    Roos M
    MMW Fortschr Med; 2005 Mar; 147(11):21. PubMed ID: 15803845
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutropenic fever of undetermined origin (N-FUO): why not use the naproxen test?
    Chang JC; Hawley HB
    Cancer Invest; 1995; 13(4):448-50. PubMed ID: 7627730
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood cancers, chemotherapy and the risks of neutropenia.
    Butters G
    Nurs Times; 2011 Mar 22-28; 107(11):19. PubMed ID: 21682165
    [No Abstract]   [Full Text] [Related]  

  • 39. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.
    Bow EJ
    Semin Hematol; 2009 Jul; 46(3):259-68. PubMed ID: 19549578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.